Table 4.
Covariate | − 2LL | AIC | p value |
---|---|---|---|
Albumin on CL | 915.873 | 935.948 | 0.33 |
Albumin on V | 922.736 | 938.562 | 0.35 |
Total protein on CL | 918.645 | 936.934 | 0.27 |
Total protein on V | 917.374 | 937.487 | 0.22 |
Creatinine on CL | 861.734 | 877.734 | 0.035 |
Creatinine on V | 893.437 | 926.475 | 0.25 |
Age on CL | 879.374 | 901.573 | 0.071 |
Age on V | 894.571 | 913.846 | 0.13 |
Weight on CL | 886.478 | 903.478 | 0.24 |
Weight on V | 861.734 | 877.734 | 0.009 |
Comorbidities on CL | 920.479 | 940.734 | 0.42 |
Comorbidities on V | 912.873 | 937.493 | 0.39 |
Concomitant use of other drugs on CL | 893.468 | 932.477 | 0.40 |
Concomitant use of other drugs on V | 927.547 | 940.750 | 0.62 |
AIC Akaike information criteria, CL clearance, POPPK population pharmacokinetic, V distribution volume, − 2LL − 2 × log-likelihood